COVID-19: Mayo Clinic is committed to taking care of our patients, learners and staff as we address the COVID-19 situation. Learn more about COVID-19 online education, resources, and live course cancellations.

Mayo Clinic Robert Kyle Symposium on Plasma Cell Disorders 2021


Share your research efforts on plasma cell disorders (monoclonal gammopathies, including but not limited to multiple myeloma, AL Amyloidosis and Waldenstrom macroglobulienmia) at the 2021 Robert A. Kyle Symposium. The Kyle Symposium is an annual event with presentations by Mayo Clinic experts, many of whom are pioneers and well recognized national and international leaders in the field of plasma cell disorders. This event will be held May 8, 2021 in the Mayo Civic Center Ballroom.

Submit abstracts
Submit poster abstracts through April 1, 2021. Abstracts will be reviewed by Mayo Clinic experts in plasma cell disorders. Top-scoring posters will be recognized at the conference. Residents and other trainees are encouraged to participate. Their abstracts will be judged in a separate trainee category.

For questions about abstract submissions, please contact Susan Reigel 


Abstract Submission
​​​​​​​An abstract must have a short, specific title, containing no abbreviations. Limit 20 words.
Select the one submission type that best describes your submission
Presenting Author Information
Select the one category that best describes your submission

Plasma Cell Disorder Abstract Guidelines

As you prepare your submission to the Meeting, please make note of the following details:

  • All types of plasma cell disorder-related research are eligible for submission
  • Abstract should address scientific questions, detail clinical and/or laboratory observations, or contain primary scientific data. 
Enter your abstract description. Limited to 250 words. (Write out all words upon first reference, followed by abbreviations in parenthesis. Include references as appropriate. Editing will not be done prior to publication, so please proofread your abstract carefully.)
Files must be less than 2 MB.
Allowed file types: pdf.
Terms of Use
All abstract submitters must agree and confirm to *ALL* of the following prior to submission. 1) I affirm that I and all others listed as authors contributed substantively to the writing, review, and work described by this abstract, and further affirm that it was not prepared or written by anyone not listed as an author. 2) I herewith confirm that the contact details saved in this system are those of the corresponding author, who will be notified about the status of the abstract. The corresponding author is responsible for informing the other authors about the status of the abstract. 3) I confirm that I am the sole owner and/or have the rights of all the information and content provided. The publication of the abstract does not infringe any third party rights including, but not limited to, intellectual property rights. I herewith grant Mayo Clinic a royalty-free, perpetual, irrevocable nonexclusive license to use, reproduce, publish, translate, distribute, and display the abstract content. 4) I confirm that I previewed this abstract and that all information is correct. I accept that the content of this abstract cannot be modified or corrected after final submission and I am aware that it will be published exactly as submitted. 5) Submission of the abstract constitutes my consent to print and/or electronic publication (e.g. meeting website, program, other promotions, etc.) 6) I confirm all requirements and that disclosure information provided is accurate, complete, and will be disclosed to participants in writing (in abstract and on poster) and verbally at the beginning of any presentation made during the meeting.

Additional Notes:

  • Projects must be complete through the Improve phase, by the time of poster creation. 
  • The poster must include numeric results.

For more Information, click on the links below. 

Frequently Asked Questions and Poster Guidelines

Website for Workshop in Plasma Cell Disorders/Robert Kyle Symposium 2020



This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.